NAMED PATIENT PROGRAM USE OF PEDMARK® TO REDUCE THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH VARIED SOLID TUMORS

Tarih

Yazarlar

Sullivan, Michael

Canpolat, Cengiz

Johnston, Robert

Ates, Dilvin Celik

Duncan, Catriona

Jorgensen, Mette

Mccarthy, Anthony

Yayınevi

URI

https://openaccess.acibadem.edu.tr/handle/11443/6130

Koleksiyonlar

Tam öğe sayfası